rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2001-6-1
|
pubmed:abstractText |
To prospectively evaluate the effectiveness, safety, and clinical benefits of once-weekly epoetin alfa therapy as an adjunct to chemotherapy in anemic cancer patients.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2875-82
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11387360-Activities of Daily Living,
pubmed-meshheading:11387360-Adolescent,
pubmed-meshheading:11387360-Adult,
pubmed-meshheading:11387360-Aged,
pubmed-meshheading:11387360-Aged, 80 and over,
pubmed-meshheading:11387360-Anemia,
pubmed-meshheading:11387360-Antineoplastic Agents,
pubmed-meshheading:11387360-Blood Transfusion,
pubmed-meshheading:11387360-Drug Administration Schedule,
pubmed-meshheading:11387360-Erythropoietin,
pubmed-meshheading:11387360-Fatigue,
pubmed-meshheading:11387360-Female,
pubmed-meshheading:11387360-Hematinics,
pubmed-meshheading:11387360-Hemoglobins,
pubmed-meshheading:11387360-Humans,
pubmed-meshheading:11387360-Injections, Subcutaneous,
pubmed-meshheading:11387360-Male,
pubmed-meshheading:11387360-Middle Aged,
pubmed-meshheading:11387360-Neoplasms,
pubmed-meshheading:11387360-Prospective Studies,
pubmed-meshheading:11387360-Quality of Life,
pubmed-meshheading:11387360-Recombinant Proteins,
pubmed-meshheading:11387360-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
|
pubmed:affiliation |
Mount Sinai Medical Center, New York, NY 10029, USA. janice.gabrilove@mssm.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|